BioSpace News Archive

Inscripta, Inc., developer of the first benchtop platform for scalable Digital Genome Engineering, today named Jim Lalonde, Ph.D. to its management team

Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, today announced the passing of long-time and valued member of the company’s Board of Directors, John H. McArthur.

The conference is being held at the Lotte New York Palace Hotel in New York City on September 8-10, 2019.

SECOND LICENSE FOR STEEP HILL IN THE SOUTH - CO-FOUNDERS ARE A LICENSED PHYSICIAN AND MEDICAL LABORATORY DIRECTOR

Ironshore Pharmaceuticals Inc. recently introduced the Rate My Mornings Quiz, an interactive tool designed to help families identify how ADHD affects their mornings.

Stefan Weber, CEO, will present at the H.C. Wainwright 21st Annual Healthcare Conference in New York, NY, on Tuesday, September 10, 2019 at 9:10 a.m. ET.

The first series of courses are scheduled to start in September 2019.

TRILUMINATE Pivotal trial is the world’s first randomized clinical trial to evaluate transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation

Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary HempMeds® Brasil has hired Gabriel Barbosa, MSc as the Company’s Scientific Projects and Regulatory Developing Analyst.

This project is focused on optimizing a neuroprotective drug candidate for traumatic brain injury and concussion and the DOD funds will support medicinal chemistry and preclinical studies in preparation for a first-in-human Phase I clinical trial.